Harrison Clinical Research

Harrison Clinical Research, a locally and globally working CRO (ISO 9001) with headquarters in Munich and offices in Europe, Israel, and USA assists at every stage of the clinical development and registration of new pharmaceutical / biotechnology products and medical devices from Phase I to Phase IV, including development consultancy, planning and performance of clinical studies, project management, monitoring, data management, statistics, medical writing, auditing, training, outsourcing, PK/PD modelling.

Website: www.harrisonclinical.com

Associate Sponsors

INTERLAB

Web: www.interlab.de

INTERLAB is an independent central laboratory supporting regional, international and global clinical trials for pharmaceutical and biotechnology companies.

INTERLAB has developed into a worldwide network covering Europe, North and South America, Australia, Africa and Asia including India and China.

Project teams assigned to coordinate study logistics are in Germany and USA. INTERLAB range of services includes routine and specialized testing (also microbiology, histo-pathology, and assay development), visit-kit building, worldwide shipping logistics and extended sample storage.

Opportunity to visit INTERLAB

INTERLAB’s European laboratory facilities are just one block away from the venue of this conference. Take the opportunity to make a short visit to INTERLAB and arrange for a visit time. Please call at +49 89 7413930 and we will be pleased to offer a lab tour. You may also come to our booth in the exhibition area.

Tel: +49 89 7413930
Email: info@INTERLAB.de
Web: www.interlab.de

VEEDA

Veeda Clinical Research® is a full service global CRO specializing in Phase I and IIa clinical research, delivering expert, cost effective research solutions to the Pharmaceutical and Biotechnology Industries worldwide.

With state-of-the-art clinical facilities, we provide fully integrated packages with access to vast population that only India can offer. From First-in-Man studies to large scale Bioequivalence/Bioavailability comparator studies, Veeda has the capabilities and expertise to take compounds from Pre-clinical to Proof of Concept.

Why Choose Veeda?

Largest and most experienced Phase 1 CRO in India
Phase I units in UK, India, Japan and Malaysia
Over 700 studies completed to date
Over 160 studies completed for USFDA submission
4 successful FDA audits and holds MHRA Phase I Supplementary Accreditation
Over 180 analytical methods offered to date
An established Biometrics team in Belgium and India which has handled over one million CRF pages.

Clinical Facilities

UK unit – 61 bed capacity with 21 monitored beds
India unit - 116 bed capacity with 12 monitored beds
Hospital-based renal unit in Nadiad, India

Areas of Expertise

Cardiovascular
Respiratory
CNS
Pain
Immunology
Infectious disease
Anaesthetics
Gastro-Intestinal
Women’s health
Elderly studies
Diabetology including Glucose Clamping
Renal disease
Oncology
Dermatology

Veeda CR’s Biometrics unit has divisions in both Europe and in India and specializes in providing high quality data management, statistics and report writing in accordance with global regulatory standards.

Veeda Oncolgy® is a global oncology company and a member of the Veeda CR Group Companies. Veeda Oncology provides outstanding oncology expertise required and expected from the pharmaceutical and biotech industries to facilitate successful Phase I to Phase IV global programs.

Veeda CR works in partnership with its clients, offering

A strong scientific and technical advisory board
Phase I/IIa studies recruited on time and to budget
Fast throughput Bioavailability/Bioequivalence/Food Effect/ Drug Interaction Studies
Clinical pathology and bioanalytical services
Specialist populations in two continents
Cost-effective and rapid data management, statistics & medical writing

Awards & Accreditations

Four successful FDA audits
ANVISA and WHO approved
Awarded the MHRA Phase I supplementary accreditation

Veeda is winner of the 2009 Frost & Sulllivan’s “Indian Clinical Research Organization of the Year” 2009 and “Partner of Choice” for Phase I studies 2007

Featured Exhibitor

ERT

ERT (www.ERT.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. Further, ERT’s ePRO Solutions™ provide a simple, immediate conduit to the Sponsor’s most valuable asset – the patient. This phone based system captures throughout the Complete Patient Experience – from Recruiting and Screening, Assessments and Diaries through to Safety and Suicidality Monitoring. ERT harnesses internet and telecommunications technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis and distribution of clinical data in all phases of clinical development.

Website: www.ERT.com